Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P17174 (
aspartate aminotransferase
)
14,872
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sepsis is the leading cause of death in intensive care units worldwide. Autophagy has recently been shown to protect against sepsis-induced liver injury. Here, we investigated the roles of
homeodomain-interacting protein kinase 2
(
HIPK2
) in the molecular mechanism of sepsis-induced liver injury.
HIPK2
expression was reduced in sepsis-induced liver injury, and
HIPK2
overexpression increased the survival rate and improved caecal ligation and puncture (CLP)-induced liver injury by reducing serum and liver
aspartate transaminase
(
AST
), alanine transaminase (ALT), and alkaline phosphatase (ALP) levels in mice with sepsis.
HIPK2
overexpression significantly decreased CLP-induced release of inflammatory cytokines into the serum and attenuated oxidative stress-associated indicators in mice with CLP-induced liver injury, whereas
HIPK2
knockdown produced the opposite results, suggesting that
HIPK2
is a negative regulator of sepsis. Furthermore,
HIPK2
overexpression inhibited lipopolysaccharide (LPS)-induced apoptosis of primary hepatocytes, increased the autophagic flux, and restored both autophagosome and autolysosome formation in the livers of CLP-induced mice by suppressing calpain signalling. Importantly,
HIPK2
overexpression reduced the elevated cytosolic Ca
2+
concentration in LPS-treated primary hepatocytes by interacting with calpain 1 and calmodulin. Finally, several anti-inflammatory drugs, including resveratrol, aspirin, vitamin E and ursolic acid, significantly increased the levels of the
HIPK2
mRNA and protein by modulating promoter activity and the 3'-UTR stability of the
HIPK2
gene. In conclusion,
HIPK2
overexpression may improve sepsis-induced liver injury by restoring autophagy and thus might be a promising target for the clinical treatment of sepsis.
...
PMID:Overexpression of homeodomain-interacting protein kinase 2 (HIPK2) attenuates sepsis-mediated liver injury by restoring autophagy. 3015 52